A new study to be presented at the SLEEP 2025 annual meeting found that sleep medicine professionals favor continuous positive airway pressure therapy as treatment for comorbid obesity and obstructive sleep apnea, while patients lean toward treatment with tirzepatide.
This article was originally published on MedicalXpress.com